Over the next nine weeks we will be hosting a series of blogs exploring some of the issues highlighted in the EFPIA Manifesto in view of the upcoming EU elections. Following last week’s vote in the European Parliament on the proposed Health Technology Assessment (HTA) Regulation, we are focusing on Improving patient access in Europe by setting up a European Clinical Assessment System that accelerates the process through harmonisation of clinical data requirements and removal of duplicative assessments.
PARADIGM’s mission is to provide a unique framework that enables structured, effective, meaningful, ethical, innovative, and sustainable patient engagement (PE) and demonstrates the ‘return on the engagement’ for all players.
European Diabetes Forum Launch Meeting - Executive Summary
On 30th September 2018, the European Diabetes Forum was launched as a multistakeholder platform in Berlin. On the eve of the 54th EASD Annual Scientific Meeting, more than 70 committed experts from research, politics, patient organisations,foundations, the medical profession, industry and many more assembled to outline the main objectives, current agenda and next steps of the Forum. You can access the executive summary here.
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.